BFLY earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E -22.40. Updated 2026-07-23.
Butterfly Network (BFLY) Research Hub
Butterfly Network (BFLY) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 7.33 USD (-1.74%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -22.40, market cap 1.68B. This hub links to the full technical, earnings and options research available for BFLY.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NYSE, US |
| Last close | 7.33 USD (-1.74%) |
| 52-week range | 5.42 USD – 9.79 USD |
| Trend regime | Range |
| 14-day RSI | 33 (Bearish) |
| Trailing P/E | -22.40 |
| Market cap | 1.68B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for BFLY
Covered Call on BFLY: how it works, illustrative setup around the real 7.33 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BFLY: how it works, illustrative setup around the real 7.33 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BFLY: how it works, illustrative setup around the real 7.33 USD price, max profit/loss, breakeven and when to use it. Educational.
BFLY technical analysis: range, last 7.33 USD, RSI 33, 52w range 5.42 USD–9.79 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is BFLY in?
Butterfly Network (BFLY) is classified under Healthcare (Medical - Devices), listed on NYSE, US.
Is BFLY in an uptrend or downtrend?
As of 2026-09-11, BFLY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BFLY's trailing P/E ratio?
BFLY's trailing P/E is -22.40, with a market cap of 1.68B. See the earnings research page for full valuation detail.
When does BFLY next report earnings?
BFLY is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of -0.03 USD.